New York Stock Exchange News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 698,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "1a158f02-0eb7-4529-8ff2-ce4d4071460e",
"title": "Global Cocoa Market Crisis: Shortages Lead to Soaring Prices",
"description": "The global cocoa market is currently facing severe shortages, leading to a significant impact on prices and trading. A dramatic increase in prices, doubling in",
"keywords": "GuruFocus, Article, News, GuruFocus Research, BRYN, HSY",
"snippet": "The global cocoa market is currently facing severe shortages, leading to a significant impact on prices and trading. A dramatic increase in prices, doubling in ...",
"url": "https://www.gurufocus.com/news/2399262/global-cocoa-market-crisis-shortages-lead-to-soaring-prices",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2024-03-28T15:17:31.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ICE",
"name": "Intercontinental Exchange, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 27.712276,
"sentiment_score": 0.0258,
"highlights": [
{
"highlight": "Efforts to stabilize the market include the <em>Intercontinental</em> <em>Exchange</em> <em>Inc</em>. (ICE) taking steps such as increasing margins and reducing the threshold for position disclosures. Additionally, ICE is gradually reducing the amount traders can buy, aiming to prevent further market squeeze.",
"sentiment": 0.0258,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "97b5bc0c-520c-440e-97fb-3c28814236d9",
"title": "What's Driving Intercorp Financial Services Inc's Surprising 14% Stock Rally?",
"description": "Intercorp Financial Services Inc (IFS) has experienced a notable fluctuation in its stock price recently. With a market capitalization of $2.9 billion, the curr",
"keywords": "GuruFocus, Article, News, GuruFocus Research, IFS, LIM:INTERBC1, LIM:SCOTIAC1, LIM:BBVAC1",
"snippet": "Intercorp Financial Services Inc (IFS, Financial) has experienced a notable fluctuation in its stock price recently. With a market capitalization of $2.9 billio...",
"url": "https://www.gurufocus.com/news/2399260/whats-driving-intercorp-financial-services-incs-surprising-14-stock-rally",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2024-03-28T15:12:05.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "IFS",
"name": "Intercorp Financial Services Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 111.50859,
"sentiment_score": 0.58615,
"highlights": [
{
"highlight": "<em>Intercorp</em> <em>Financial</em> <em>Services</em> <em>Inc</em> (IFS, Financial) has experienced a notable fluctuation in its stock price recently. With a market capitalization of $2.9 billion, the current stock price stands at $25. Over the past week, the stock has seen an 11.19% decline, yet when looking at the past three months, there is a 13.81% gain.",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "Company Overview\n\n<em>Intercorp</em> <em>Financial</em> <em>Services</em> <em>Inc</em>, operating in the banking industry, provides a comprehensive range of financial services. These include banking, insurance, wealth management, and payment services through its recent integration of Izipay.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
},
{
"highlight": "Conclusion\n\nIn conclusion, <em>Intercorp</em> <em>Financial</em> <em>Services</em> Inc's stock performance over the past three months has been impressive, with a 13.81% gain, despite a recent weekly loss of 11.19%. The company is currently fairly valued according to GF Value, reflecting its recent price movements.",
"sentiment": 0.9078,
"highlighted_in": "main_text"
},
{
"highlight": "What's Driving <em>Intercorp</em> <em>Financial</em> <em>Services</em> Inc's Surprising 14% Stock Rally?",
"sentiment": 0.2732,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "06788fe0-dc1b-4779-8d1c-7f8f373f0572",
"title": "SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Xponential Fitness",
"description": "NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against...",
"keywords": "Faruqi & Faruqi LLP, Faruqi & Faruqi, Faruqi Law, Class Action, Class Action Lawsuit, NYSE, XPOF, Xponential, Xponential Fitness",
"snippet": "NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Xponential ...",
"url": "https://www.globenewswire.com/news-release/2024/03/28/2854192/683/en/SHAREHOLDER-ACTION-REMINDER-Faruqi-Faruqi-LLP-Investigates-Claims-on-Behalf-of-Investors-of-Xponential-Fitness.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/8628babf-2ea4-4b8a-a60b-260db109bfa2",
"language": "en",
"published_at": "2024-03-28T14:55:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "XPOF",
"name": "Xponential Fitness, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 103.88817,
"sentiment_score": 0.134417,
"highlights": [
{
"highlight": "NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against <em>Xponential</em> <em>Fitness</em>, <em>Inc</em>.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "(“<em>Xponential</em> <em>Fitness</em>” or the “Company”) (<em>NYSE</em>: <em>XPOF</em>) and reminds investors of the April 9, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In <em>Xponential</em> <em>Fitness</em> To Contact Him Directly To Discuss Their Options\n\nIf you suffered losses exceeding $50,000 investing in <em>Xponential</em> <em>Fitness</em> stock or options between July 26, 2021 and December 7, 2023 and would like to",
"sentiment": -0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "You may also click here for additional information: www.faruqilaw.com/<em>XPOF</em>.\n\nFaruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Faruqi & Faruqi, LLP also encourages anyone with information regarding <em>Xponential</em> <em>Fitness</em>’ conduct to contact the firm, including whistleblowers, former employees, shareholders and others.\n\nAttorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).",
"sentiment": 0.6369,
"highlighted_in": "main_text"
},
{
"highlight": "SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of <em>Xponential</em> <em>Fitness</em>",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "3be3c671-9602-49a8-b85f-daec7f75477c",
"title": "UPSwing: Why This Delivery Giant May Be Poised For Takeoff (NYSE:UPS)",
"description": "UPS is focusing on efficiency and growth in healthcare logistics and e-commerce returns, despite challenges. Read more on UPS stock here.",
"keywords": "",
"snippet": "SCM Jeans/iStock Editorial via Getty Images\n\nIntroduction\n\nIt's time to discuss United Parcel Service (NYSE:UPS), a stock I haven't covered since November 13, 2...",
"url": "https://seekingalpha.com/article/4680975-upswing-why-this-delivery-giant-may-be-poised-for-takeoff",
"image_url": "https://media.gettyimages.com/id/1476359348/de/foto/united-parcel-service-b747.jpg?b=1&s=170667a&w=0&k=20&c=10OJ3pk7TrtTDeOhvQJgWUJTgR7kp3kpcaEQcZxJybY=",
"language": "en",
"published_at": "2024-03-28T14:54:00.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "UPS",
"name": "United Parcel Service, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 62.392735,
"sentiment_score": 0.427455,
"highlights": [
{
"highlight": "SCM Jeans/iStock Editorial via Getty Images\n\nIntroduction\n\nIt's time to discuss <em>United</em> <em>Parcel</em> <em>Service</em> (<em>NYSE:UPS</em>), a stock I haven't covered since November 13, 2023.\n\nBack then, I went with the title \"Down 40%, 5%-Yielding UPS Is Getting Attractive.\"\n\nOne of the problems I always had with UPS is its poor total return.",
"sentiment": -0.7003,
"highlighted_in": "main_text"
},
{
"highlight": "<em>United</em> <em>Parcel</em> <em>Service</em>\n\nThis expansion achieves two things:\n\nIt helps UPS to tap into a highly lucrative market, as healthcare shipments often include high-value products.\n\nIt facilitates innovation and meets changing consumer demands.\n\nIt also needs to be said that this market is bigger than one might have expected.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
},
{
"highlight": "<em>United</em> <em>Parcel</em> <em>Service</em>\n\nRelated to this strategic shift, the company is moving into other segments, including small and medium-sized businesses (SMBs) and supply chain solutions.",
"sentiment": 0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "<em>United</em> <em>Parcel</em> <em>Service</em>\n\nFurthermore, strategic acquisitions, including Roadie delivery solutions and Happy Returns, have further improved the company's portfolio.\n\nThese improvements allow UPS to offer solutions tailored to the needs of SMBs and e-commerce customers. This goes beyond \"generic\" parcel services.",
"sentiment": 0.9081,
"highlighted_in": "main_text"
},
{
"highlight": "<em>United</em> <em>Parcel</em> <em>Service</em>\n\nIt also has something called a \"1+2 plan\".\n\nAs one can imagine, the 1+2 plan consists of two key components.\n\nThe \"1\" represents the first year and the \"2\" stands for the subsequent two years of the strategic roadmap.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>United</em> <em>Parcel</em> <em>Service</em>\n\nWith that in mind, it's important to mention that the company's plans to benefit from emerging markets and changing trends include China and shifting supply chains.",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "<em>United</em> <em>Parcel</em> <em>Service</em>\n\nRelocating supply chains is extremely difficult, as it often requires changing relationships and operations that have been built over multiple decades.\n\nHence, UPS aims to use its improved network and end-to-end solutions to support companies in these endeavors.",
"sentiment": 0.577,
"highlighted_in": "main_text"
},
{
"highlight": "<em>United</em> <em>Parcel</em> <em>Service</em>\n\nPersonally, I'm very bullish on these operations, as I have been on top of these economic re-shoring and de-globalization trends since the pandemic.\n\nThese inflationary trends are good news for companies with the capabilities to support clients to reshape supply chains.",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "<em>United</em> <em>Parcel</em> <em>Service</em>\n\nEven better, the company aims to grow free cash flow to roughly $7 billion by 2026. This would imply a 5.5% free cash flow yield based on its current $126 billion market cap.\n\nThis bodes well for its investors.",
"sentiment": 0.891,
"highlighted_in": "main_text"
},
{
"highlight": "<em>United</em> <em>Parcel</em> <em>Service</em>\n\nAfter hiking its quarterly dividend by a penny (0.6%) to $1.63 per share on January 30, it currently yields 4.4%.\n\nThis dividend is protected by a $8.28 in expected 2024 EPS. This implies a 79% payout ratio. Next year, EPS is expected to rise to $9.75, implying a 66% payout ratio.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "UPSwing: Why This Delivery Giant May Be Poised For Takeoff (<em>NYSE:UPS</em>)",
"sentiment": 0.25,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "8a50507c-33ec-471d-90c2-43c9b4e88a47",
"title": "Labcorp to acquire BioReference Health assets for $237.5 million By Investing.com",
"description": "Labcorp to acquire BioReference Health assets for $237.5 million",
"keywords": "",
"snippet": "BURLINGTON, N.C. - Labcorp (NYSE: LH) and OPKO Health, Inc. (Nasdaq: OPK) announced an agreement for Labcorp to purchase select assets of OPKO's subsidiary, Bio...",
"url": "https://www.investing.com/news/company-news/labcorp-to-acquire-bioreference-health-assets-for-2375-million-93CH-3357149",
"image_url": "https://i-invdn-com.investing.com/news/international_newspapers_69x52._800x533_L_1419494241.jpg",
"language": "en",
"published_at": "2024-03-28T14:50:47.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "LAZ",
"name": "Lazard Ltd",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 15.982258,
"sentiment_score": 0.128,
"highlights": [
{
"highlight": "Financial advisory services for the deal are provided by <em>Lazard</em> (NYSE: ) for Labcorp and Piper Sandler & Co. for OPKO, with legal counsel from Hogan Lovells, Kilpatrick Townsend, Parker Poe, and Greenberg Traurig.\n\nThis transaction is based on a press release statement.",
"sentiment": 0.128,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "cf2d7f0e-27ab-40fb-8301-cf339476c736",
"title": "Pennsylvania County Joins List of Local Govts Suing Big Oil over Climate",
"description": "The county of Bucks in Pennsylvania seeks to charge climate remedial measures to oil and gas giants.",
"keywords": "oil and gas petroleum news events stories articles analysis commentary headlines stocks finance commodities maps pictures",
"snippet": "The county of Bucks in Pennsylvania seeks to charge climate remedial measures to oil and gas giants.\n\nThe county of Bucks in Pennsylvania has taken oil and gas ...",
"url": "https://www.rigzone.com/news/pennsylvania_county_joins_list_of_local_govts_suing_big_oil_over_climate-28-mar-2024-176230-article/",
"image_url": "https://images.rigzone.com/images/news/articles/Pennsylvania-County-Joins-List-of-Local-Govts-Suing-Big-Oil-over-Climate-176230-582x327.png",
"language": "en",
"published_at": "2024-03-28T14:48:40.000000Z",
"source": "rigzone.com",
"relevance_score": null,
"entities": [
{
"symbol": "PSX",
"name": "Phillips 66",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 25.784775,
"sentiment_score": -0.39875,
"highlights": [
{
"highlight": "., <em>Phillips</em> <em>66</em> Co., Shell PLC and industry group the American Petroleum Institute (API).\n\nIndustry reaction to the suit highlighted it has existed to meet energy needs and that local courtrooms have no power to decide national climate policy.",
"sentiment": -0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Phillips</em> <em>66</em> also declined to comment.\n\nBefore Bucks, similar cases against the oil and gas industry for alleged climate fraud or damages had been filed by several city, county and state governments.",
"sentiment": -0.7717,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "e27a3c2e-d9b2-43da-a569-3352669cd2f0",
"title": "Stifel raises Now Inc stock target, maintains buy rating By Investing.com",
"description": "Stifel raises Now Inc stock target, maintains buy rating",
"keywords": "",
"snippet": "On Thursday, Stifel took a positive stance on Now Inc (NYSE: DNOW), raising the industrial products and equipment distributor's price target to $18 from $16, wh...",
"url": "https://www.investing.com/news/company-news/stifel-raises-now-inc-stock-target-maintains-buy-rating-93CH-3357142",
"image_url": "https://i-invdn-com.investing.com/news/international_newspapers_69x52._800x533_L_1419494241.jpg",
"language": "en",
"published_at": "2024-03-28T14:43:39.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "DNOW",
"name": "NOW Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 62.315075,
"sentiment_score": 0.444014,
"highlights": [
{
"highlight": "On Thursday, Stifel took a positive stance on <em>Now</em> <em>Inc</em> (<em>NYSE</em>: <em>DNOW</em>), raising the industrial products and equipment distributor's price target to $18 from $16, while reiterating a Buy rating on the stock.",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Now</em> <em>Inc</em> intends to manage Whitco separately from its core distribution business while seeking revenue synergies between the two entities.\n\nThe company's acquisition strategy is also geared toward expanding its pump business and diversifying into energy transition, carbon capture, utilization and storage (CCUS), and midstream markets.",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Despite the anticipation of flat markets in upstream distribution for the year, <em>Now</em> <em>Inc</em> aims to outperform the market by capturing additional market share through superior customer service.",
"sentiment": 0.6791,
"highlighted_in": "main_text"
},
{
"highlight": "InvestingPro Insights\n\nFollowing Stifel's positive outlook on <em>Now</em> <em>Inc</em> (<em>NYSE</em>: <em>DNOW</em>), current metrics from InvestingPro reinforce the company's strong financial position.",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "With a market capitalization of approximately $1.62 billion and a notably low price-to-earnings (P/E) ratio of 6.67, <em>Now</em> <em>Inc</em> is trading at an attractive earnings multiple, which may interest value-focused investors. The company's P/E ratio has remained consistent in the last twelve months as of Q4 2023, sitting at 6.48.",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "InvestingPro Tips indicate that <em>Now</em> <em>Inc</em> holds more cash than debt, which is a testament to its solid balance sheet, and liquid assets exceed short-term obligations, providing financial flexibility. This aligns with the company's strategic capital deployment mentioned by Stifel.",
"sentiment": 0.228,
"highlighted_in": "main_text"
},
{
"highlight": "Stifel raises <em>Now</em> <em>Inc</em> stock target, maintains buy rating By Investing.com",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "57aa125b-6f7a-46f8-8e5e-a414c67228ea",
"title": "Evolent Health stock target cut by Canaccord, retains buy rating By Investing.com",
"description": "Evolent Health stock target cut by Canaccord, retains buy rating",
"keywords": "",
"snippet": "On Thursday, Canaccord Genuity adjusted its price target for Evolent Health (NYSE: ), reducing it to $44 from $45, while sustaining a Buy rating on the stock. T...",
"url": "https://www.investing.com/news/company-news/evolent-health-stock-target-cut-by-canaccord-retains-buy-rating-93CH-3357006",
"image_url": "https://i-invdn-com.investing.com/news/World_News_9_800x533_L_1420026261.jpg",
"language": "en",
"published_at": "2024-03-28T13:29:30.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "EVH",
"name": "Evolent Health, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 73.6589,
"sentiment_score": -0.064,
"highlights": [
{
"highlight": "On Thursday, Canaccord Genuity adjusted its price target for <em>Evolent</em> <em>Health</em> (NYSE: ), reducing it to $44 from $45, while sustaining a Buy rating on the stock. The adjustment follows a review of the company's financial year 2024 and 2025 estimates to more accurately represent Evolent's gross margin trajectory.",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "InvestingPro Insights\n\nAs <em>Evolent</em> <em>Health</em> (<em>NYSE:EVH</em>) navigates its business trajectory, real-time data from InvestingPro offers a glimpse into the company's financial health and market position. With a market capitalization of $3.66 billion, Evolent's stock price movements have been noted for their volatility.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "For those interested in a deeper analysis, InvestingPro offers several additional tips on <em>Evolent</em> <em>Health</em>, which can be accessed with an exclusive offer. Use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, enriching your investment strategy with informed insights.",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Evolent</em> <em>Health</em> stock target cut by Canaccord, retains buy rating By Investing.com",
"sentiment": -0.2732,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "f813a844-3e19-4544-946e-cdcf8192a2a4",
"title": "Goldman Sachs reiterates Buy on Moderna stock, cites Blackstone deal By Investing.com",
"description": "Goldman Sachs reiterates Buy on Moderna stock, cites Blackstone deal",
"keywords": "",
"snippet": "On Thursday, Goldman Sachs reaffirmed its Buy rating on Moderna (NASDAQ: ) stock, keeping the price target at $206.00. Moderna, listed on NASDAQ:MRNA, recently ...",
"url": "https://www.investing.com/news/company-news/goldman-sachs-reiterates-buy-on-moderna-stock-cites-blackstone-deal-93CH-3356331",
"image_url": "https://i-invdn-com.investing.com/news/Moderna_800x533_L_1608131517.jpg",
"language": "en",
"published_at": "2024-03-28T10:01:54.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "MRNA",
"name": "Moderna, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 39.793175,
"sentiment_score": 0.20713,
"highlights": [
{
"highlight": "On Thursday, Goldman Sachs reaffirmed its Buy rating on <em>Moderna</em> (NASDAQ: ) stock, keeping the price target at $206.00. <em>Moderna</em>, listed on <em>NASDAQ:MRNA</em>, recently held its fifth Vaccines Day, during which several key updates were shared.",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "This partnership is expected to alleviate some of the R&D costs for <em>Moderna</em>, with returns based on commercial milestones and low-single-digit royalties. A regulatory filing for the flu vaccine is anticipated in 2024.",
"sentiment": -0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "In addition to the Blackstone partnership, <em>Moderna</em> reported positive clinical data from three vaccine candidates that are moving into Phase 3 trials: Epstein-Barr virus, Varicella-Zoster virus, and norovirus.\n\nThe total addressable market for these and other vaccines, excluding respiratory vaccines, is estimated by <em>Moderna</em> to be over $25 billion.",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> also provided information on its next-generation COVID-19 vaccine, which is being designed to be stable in a refrigerator.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Overall, Goldman Sachs views the developments as a sign of significant opportunities emerging for <em>Moderna</em> beyond its COVID-19 vaccine, including the individualized neoantigen therapy being developed in partnership with Merck.",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "InvestingPro Insights\n\nAs <em>Moderna</em> continues to advance its diverse vaccine portfolio, real-time data from InvestingPro offers a snapshot of the company's current financial health and market performance. With a market capitalization of $42.34 billion, <em>Moderna</em> shows a significant presence in the biotechnology sector.",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "This financial stability could be crucial as <em>Moderna</em> invests in the development of its flu vaccine in collaboration with Blackstone Life Sciences and prepares for upcoming Phase 3 trials of other vaccine candidates.",
"sentiment": -0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, while analysts have revised their earnings downwards for the upcoming period and anticipate a sales decline in the current year, <em>Moderna</em> has demonstrated strong returns over the last month with a price total return of 13.45%.",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "To enhance your investment research, consider using the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro, where you can find a total of 13 InvestingPro Tips for <em>Moderna</em>.\n\nThis article was generated with the support of AI and reviewed by an editor. For more information see our T&C.",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "Goldman Sachs reiterates Buy on <em>Moderna</em> stock, cites Blackstone deal By Investing.com",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "BX",
"name": "The Blackstone Group Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 13.031212,
"sentiment_score": 0.5574,
"highlights": [
{
"highlight": "In addition to <em>the</em> <em>Blackstone</em> partnership, Moderna reported positive clinical data from three vaccine candidates that are moving into Phase 3 trials: Epstein-Barr virus, Varicella-Zoster virus, and norovirus.\n\nThe total addressable market for these and other vaccines, excluding respiratory vaccines, is estimated by Moderna to be over $25 billion.",
"sentiment": 0.5574,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MRK",
"name": "Merck & Co., Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 11.580635,
"sentiment_score": 0.5267,
"highlights": [
{
"highlight": "Overall, Goldman Sachs views the developments as a sign of significant opportunities emerging for Moderna beyond its COVID-19 vaccine, including the individualized neoantigen therapy being developed in partnership with <em>Merck</em>.",
"sentiment": 0.5267,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MRK-WI",
"name": "Merck & Company, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 11.580667,
"sentiment_score": 0.5267,
"highlights": [
{
"highlight": "Overall, Goldman Sachs views the developments as a sign of significant opportunities emerging for Moderna beyond its COVID-19 vaccine, including the individualized neoantigen therapy being developed in partnership with <em>Merck</em>.",
"sentiment": 0.5267,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "770d4ce4-b2f7-4dfd-90fc-170ed3126c6f",
"title": "RENN Fund CEO Murray Stahl buys $91 worth of company stock By Investing.com",
"description": "RENN Fund CEO Murray Stahl buys $91 worth of company stock",
"keywords": "",
"snippet": "In a recent transaction reported on March 27, 2024, Murray Stahl, President and CEO of RENN Fund, Inc. (NYSE:RCG), purchased shares of the company's common stoc...",
"url": "https://www.investing.com/news/company-news/renn-fund-ceo-murray-stahl-buys-91-worth-of-company-stock-93CH-3357140",
"image_url": "https://i-invdn-com.investing.com/news/news_six_pile_69x52._800x533_L_1419494215.jpg",
"language": "en",
"published_at": "2024-03-28T14:42:16.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "RCG",
"name": "RENN Fund, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 105.2788,
"sentiment_score": 0.484514,
"highlights": [
{
"highlight": "In a recent transaction reported on March 27, 2024, Murray Stahl, President and CEO of <em>RENN</em> <em>Fund</em>, <em>Inc</em>. (<em>NYSE:RCG</em>), purchased shares of the company's common stock. The transaction, which is part of the executive's regular financial activities, saw Stahl acquiring additional shares at a price of $1.60 each, totaling an investment of $91.",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "Stahl, who holds a dual role as both a director and an officer of <em>RENN</em> <em>Fund</em>, has increased his direct holdings in the company through this acquisition. Following the transaction, Stahl's direct ownership in <em>RENN</em> <em>Fund</em> stands at 4,972 shares.\n\nIn addition to his direct holdings, Stahl has indirect interests through several entities.",
"sentiment": 0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "<em>RENN</em> <em>Fund</em>, <em>Inc</em>., headquartered in Dallas, Texas, is known for its previous names, RENN Global Entrepreneurs Fund, Inc., and Renaissance Capital Growth & Income Fund III Inc. The company's activities and executive transactions are routinely disclosed in compliance with SEC regulations, providing transparency to investors and the market.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "InvestingPro Insights\n\nIn light of the recent share purchase by Murray Stahl, President and CEO of <em>RENN</em> <em>Fund</em>, <em>Inc</em>. (<em>NYSE:RCG</em>), investors may find it valuable to consider the current financial health and performance metrics of the company.",
"sentiment": 0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "According to real-time data from InvestingPro, <em>RENN</em> <em>Fund</em> has had a revenue growth of 27.92% over the last twelve months as of Q4 2023, with quarterly revenue growth also showing a positive trend at 26.26%.",
"sentiment": 0.8316,
"highlighted_in": "main_text"
},
{
"highlight": "For investors seeking a deeper analysis, there are additional InvestingPro Tips available for <em>RENN</em> <em>Fund</em> at https://www.investing.com/pro/RCG. These tips can provide further guidance on the potential risks and opportunities associated with the company's stock.",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "<em>RENN</em> <em>Fund</em> CEO Murray Stahl buys $91 worth of company stock By Investing.com",
"sentiment": 0.2263,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "5850b138-2164-46a8-b122-6fade6ac922f",
"title": "XPH: A More Balanced Way To Get Exposure To Pharmaceuticals",
"description": "SPDR S&P Pharmaceuticals ETF offers broad-based exposure to the U.S. pharmaceuticals sector. Click here to read my analysis of XPH ETF.",
"keywords": "",
"snippet": "Trevor Williams\n\nCertain pharmaceutical companies like Eli Lilly have been on fire given the demand for GLP-1 and weight loss medications, but the broader indus...",
"url": "https://seekingalpha.com/article/4680973-xph-more-balanced-way-to-get-exposure-to-pharmaceuticals",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1635084121/image_1635084121.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-03-28T14:38:32.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "LLY",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 27.892527,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>Eli</em> <em>Lilly</em> <em>and</em> <em>Company</em> (LLY): a global pharmaceutical leader that develops and markets a wide range of medicines in several therapeutic areas, including diabetes, cancer, and autoimmune diseases, with a commitment to research and improving patient outcomes. The weighting is 4.70%. Merck & Co., Inc.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MRK",
"name": "Merck & Co., Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 17.980534,
"sentiment_score": 0.8402,
"highlights": [
{
"highlight": "<em>Merck</em> & <em>Co</em>., <em>Inc</em>. (MRK): a leading global healthcare company that offers innovative prescription medicines, vaccines, biologic therapies, and animal health products, with a strong focus on scientific research and improving global health. The weighting is 4.70%. Pfizer Inc.",
"sentiment": 0.8402,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFE",
"name": "Pfizer Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 13.65911,
"sentiment_score": 0.8481,
"highlights": [
{
"highlight": "<em>Pfizer</em> <em>Inc</em>. (PFE): a premier biopharmaceutical corporation with a diverse portfolio that includes blockbuster drugs, a robust pipeline of innovative therapies, and a leading presence in areas such as immunology, oncology, cardiology, and vaccines. The weighting is 4.69%.",
"sentiment": 0.8481,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PFE-WI",
"name": "Pfizer, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 13.659129,
"sentiment_score": 0.8481,
"highlights": [
{
"highlight": "<em>Pfizer</em> <em>Inc</em>. (PFE): a premier biopharmaceutical corporation with a diverse portfolio that includes blockbuster drugs, a robust pipeline of innovative therapies, and a leading presence in areas such as immunology, oncology, cardiology, and vaccines. The weighting is 4.69%.",
"sentiment": 0.8481,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "22913efb-2187-4148-a03a-a74b1b76e7f9",
"title": "Vizio drops amid opinion piece about antitrust scrutiny of Walmart deal (NYSE:VZIO)",
"description": "An opinion piece suggests that Walmart's planned acquisition of Vizio may face regulatory concerns similar to Amazon's attempted purchase of iRobot.",
"keywords": "",
"snippet": "Vizio (NYSE:VZIO) fell 1.1% amid an opinion piece that argues Walmart's (NYSE:WMT) planned acquisition appears similar to Amazon's (AMZN) attempted purchase of ...",
"url": "https://seekingalpha.com/news/4084994-vizio-drops-amid-opinion-piece-about-antitrust-scutiny-of-walmart-deal",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1369415685/image_1369415685.jpg?io=getty-c-w750",
"language": "en",
"published_at": "2024-03-28T14:38:31.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "WMT",
"name": "Walmart Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Defensive",
"match_score": 38.761326,
"sentiment_score": 0.066925,
"highlights": [
{
"highlight": "Vizio (NYSE:VZIO) fell 1.1% amid an opinion piece that argues Walmart's (<em>NYSE:WMT</em>) planned acquisition appears similar to Amazon's (AMZN) attempted purchase of iRobot (IRBT), which was terminated on fears that the regulators would block it.",
"sentiment": -0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "The opinion piece comes after <em>Walmart</em> (WMT) on Wednesday disclosed that it has pulled and will refile its HSR notification for its planned $2.3 billion acquisition of TV maker Vizio (VZIO). Walmart's HSR notification was withdrawn effective on Wednesday, according to an 8-K filing. The retailer expects to refile on Friday.",
"sentiment": 0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Walmart</em> (WMT) confirmed last month that it was acquiring Vizio (VZIO) for $11.50 per share in cash, which works out to a fully diluted equity value of approximately $2.3 billion.",
"sentiment": 0.5984,
"highlighted_in": "main_text"
},
{
"highlight": "Vizio drops amid opinion piece about antitrust scrutiny of <em>Walmart</em> deal (NYSE:VZIO)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "NYSE",
"total_documents": 1107,
"sentiment_avg": 0.25542307498761246
}
]
}
Other details
Country
- us
- 4,171